Clinical Trial Update: An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets [Phase 3]

View source ↗

Summary

Phase 3 trial update for BMS-512148 in combination with metformin for type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-512148
• Metformin Extended-Release Tablets (metformin extended-release)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2017-02-23